Eli Lilly, one of the major producers of insulin for the U.S., reassured consumers and the market today, saying it does not expect any shortages of its products as the COVID-19 outbreak spreads around the world.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,